![Juan Frias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Juan Frias
Direktor/Vorstandsmitglied bei
T1D Exchange
Vermögen: - $ am 30.06.2026
Profil
Juan Pablo Frias is currently Director at T1D Exchange.
Formerly, Dr. Frias was Chief Executive Officer at National Research Institute from 2013 to 2020.
Dr. Frias was President & Chief Executive Officer at NRI Clinical Research LLC.
Dr. Frias was Medical Director at Velocity Clinical Research, Inc. Dr. Frias was Chief Medical Officer & Head-Diabetes at Biomea Fusion, Inc. Dr. Frias was Chief Medical Officer at Johnson & Johnson from 2007 to 2010.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 31.03.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Juan Frias
| Unternehmen | Position | Beginn |
|---|---|---|
T1D Exchange
 T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Juan Frias
| Unternehmen | Position | Ende |
|---|---|---|
National Research Institute
 National Research Institute BiotechnologyHealth Technology Provides innovative therapies for health care | Vorstandsvorsitzender | 01.10.2020 |
| JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2010 |
Velocity Clinical Research, Inc.
 Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Operates as a clinical research sites | Technik-/Wissenschafts-/F&E-Leiter | - |
| BIOMEA FUSION, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
NRI Clinical Research LLC
 NRI Clinical Research LLC BiotechnologyHealth Technology Owns and operates clinical research center | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
National Research Institute
National Research Institute BiotechnologyHealth Technology Provides innovative therapies for health care | Health Technology |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology Owns and operates clinical research center | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Health Technology |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Operates as a clinical research sites | Technology Services |
Biomea Fusion, Inc.
 Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
